Evidence map›Paper›PMID 39976178›Full record

ArticleAnnals of neurology2025

Brain Metabolic Features of FUS-ALS: A 2-[

Antonio Canosa, Umberto Manera, Rosario Vasta, Grazia Zocco, Francesca Di Pede, Sara Cabras, Filippo De Mattei, Francesca Palumbo, Barbara Iazzolino, Emilio Minerva and 15 more

Abstract read
In one paragraph

Article in Annals of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Antonio CanosaALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0001-5876-4079
Umberto ManeraALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Rosario VastaALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0002-0393-4736
Grazia ZoccoALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Francesca Di PedeALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Sara CabrasALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Filippo De MatteiALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Francesca PalumboALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Barbara IazzolinoALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Emilio MinervaALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Luca SbaizDepartment of Clinical Pathology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Laboratory of Genetics, Turin, Italy.
Maura BrunettiDepartment of Clinical Pathology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Laboratory of Genetics, Turin, Italy.
Salvatore GalloneAzienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Neurology Unit 1U, Turin, Italy.
Maurizio GrassanoALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Enrico MatteoniALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Giulia PolverariPositron Emission Tomography Center AFFIDEA-IRMET S.p.A, Turin, Italy.
Giuseppe FudaALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Federico CasaleALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Paolina SalamoneALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Giovanni De MarcoALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Giulia MarcheseALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Cristina MogliaALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Andrea CalvoALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0002-5122-7243
Marco Pagani *Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy.
Adriano Chiò *ALS Center, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.ORCID 0000-0001-9579-5341

Funding

A.S.D. Polisportiva U.I.C.I Torino Onlus (Oltre la Vista, Oltre la SLA)European Commission's Health Seventh Framework Programme (FP7/2007-2013) 259867Fondation Thierry Latran (INSPIRED)Horizon 2020 Framework Programme 101137074Horizon 2020 Framework Programme (BRAINTEASER [Bringing Artificial Intelligence Home for a Better Care of Amyotrophic Lateral Sclerosis and Multiple Sclerosis]) GA101017598Ministero della Salute (The Italian Ministry of Health [Ricerca Sanitaria Finalizzata]) RF-2016- 02362405Ministero dell'Università e della Ricerca 2017SNW5MBMinistero dell'Università e della Ricerca PRIN 2017
6 · The paper itself

Abstract

objectiveWe aimed at evaluating the brain metabolic features of fused in sarcoma amyotrophic lateral sclerosis (FUS-ALS) compared with sporadic ALS (sALS), using 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography (2-[

methodsWe employed the 2-sample t-test model of SPM12, implemented in MATLAB, to compare 12 FUS-ALS cases with 40 healthy controls (HC) and 48 sALS, randomly collected from the series of patients who underwent brain 2-[

resultssALS patients showed significant relative hypometabolism in bilateral fronto-temporo-occipital cortex and right insula as compared with FUS-ALS. After adjusting for age, the relative hypometabolism remained in the bilateral precentral gyrus and in the right middle and inferior temporal gyrus. As compared with HC, FUS patients displayed a significant relative hypermetabolism in the pontobulbar region and right cerebellar tonsil, dentate nucleus, and uvula, while sALS showed relative hypometabolism in bilateral frontal and occipital cortices and in left temporal and parietal regions.

interpretationPatients with FUS-ALS show relative preservation of motor cortex metabolism compared with those with sALS, possibly reflecting the prevalence of lower motor neuron impairment in their phenotype. Prospective studies are necessary to investigate the possible role of 2-[

Indexed as

Amyotrophic Lateral SclerosisBrainRNA-Binding Protein FUSAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18FUS protein, humanRadiopharmaceuticalsRNA-Binding Protein FUS

Identifiers

PMID39976178
PMCPMC12081991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.